Drug Shortage Report for DIMENHYDRINATE INJECTION USP

Last updated on 2022-06-07 History
Report ID 158877
Drug Identification Number 02428954
Brand name DIMENHYDRINATE INJECTION USP
Common or Proper name DIMENHYDRINATE INJECTION USP
Company Name HIKMA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) DIMENHYDRINATE
Strength(s) 50MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR
Packaging size 1mL
ATC code R06AA
ATC description
Reason for shortage Delay in shipping of the drug.
Anticipated start date
Actual start date 2022-04-14
Estimated end date 2022-05-15
Actual end date 2022-05-15
Shortage status Resolved
Updated date 2022-06-07
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 5995 AVEBURY ROAD, SUITE 804
MISSISSAUGA, ONTARIO
CANADA L5R 3P9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v6 2022-06-07 French Compare
v5 2022-06-07 English Compare
v4 2022-04-15 English Compare
v3 2022-04-14 French Compare
v2 2022-04-14 English Compare
v1 2022-04-14 English Compare

Showing 1 to 6 of 6